Baseline normal values and phylogenetic class of the electrocardiogram of anesthetized free-ranging brown bears (Ursus arctos).

Electrocardiographic (ECG) variables were measured in 22 healthy, free-ranging brown bears (Ursus arctos) anesthetized with a combination of medetomidine, tiletamine, and zolazepam during research and management operations in south-central Sweden. Six-limb lead ECGs and the base-apex lead were recorded. Morphologies, amplitudes, rhythms, and durations of P waves, PQ intervals, QRS complexes, T waves, QT intervals, and QT intervals corrected for heart rate (QTc) were calculated from the base-apex lead. The mean electrical axis (MEA) for each individual was approximated in the frontal plane from the heights of R waves in leads I (X axis) and aVF (Y axis). All 22 bears had sinus rhythms and 10 of them had respiratory sinus arrhythmia. Heart rates ranged from 43 to 103 beats per minute and were independent of body mass. The MEA was 78.6 (+ or - 5.5) degrees. Some bears had strikingly peaked T waves, and many had pronounced notching (high frequency components) to the QRS complex. This information contributes to the limited data base of electrocardiography for brown bears and elucidates ECG similarities with other species in the order Carnivora.

The pharmacokinetics of orally administered ivermectin in African elephants (Loxodonta africana): implications for parasite elimination.

Loxodonta africana are susceptible to a wide variety of parasites that are often treated with the broad spectrum antiparasitic ivermectin (IVM) based on empirical knowledge. The objectives of this study were to 1) measure plasma IVM levels following administration of 0.1 mg/kg IVM p.o., 2) compare plasma IVM levels following administration with regular versus restricted feed rations, 3) measure IVM excretion in feces, and 4) use these findings to generate dosing recommendations for this species. Using a crossover design, six African elephants were divided into two groups. Ivermectin was administered and typical grain rations were either provided or withheld for 2 hr. Blood and fecal samples were collected for 7 days following drug administration. After a 5-wk washout period, groups were switched and the procedure repeated. Plasma and fecal IVM were analyzed using high-performance liquid chromatography. There was no statistically significant difference detected in the pharmacokinetic data between the fed and fasted groups. Peak plasma concentration, area under the curve, and half-life for plasma ranged between 5.41-8.49 ng/ml, 17.1-20.3 ng x day/ml, and 3.12-4.47 day, respectively. High IVM concentrations were detected in feces. The peak concentration values in feces were between 264-311-fold higher than those obtained in plasma. The comparatively large area under the curve and short time to maximum concentration in feces indicate elimination prior to absorption of much of the drug. Plasma IVM concentrations were low when compared to other species. Based on these findings, administration of 0.2-0.4 mg/kg p.o. should be appropriate for eliminating many types of parasites in elephants, and could minimize development of parasite resistance.

Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).

Vaccination has been an important component of preventative health care programs of North American zoologic institutions in their protection of valuable species against West Nile virus (WNV) infection since its detection in 1999. Although approved only for horses, commercial WNV vaccine has been used for the purpose of protection of nondomestic species, including avian, equid, and rhinoceros species. Currently, there are two commercial equine vaccines available, a killed vaccine and a recombinant viral-vectored vaccine. Both products have been used for the vaccination of Greater One-horned rhinoceroses (Rhinoceros unicornis) held in North American zoologic institutions. In this study, the efficacy of these vaccines was evaluated in Greater One-horned rhinoceroses based on the humoral immune response stimulated by vaccine administration. Five rhinoceroses were vaccinated in 2005 by using the killed equine vaccine and four received boosters in 2006 by using the recombinant vaccine. Rhinoceroses were evaluated for differences in pre- and postvaccination neutralizing antibody titer and gamma and beta globulins on serum protein electrophoresis. No changes were observed after administration of the killed vaccine; however, antibody titers were observed in two of four rhinoceroses after administration of the recombinant vaccine. No significant changes were observed in the serum protein electrophoresis after either vaccine. Based on these findings, the WNV recombinant vaccine appeared to induce a more measurable humoral immune response than the killed product in the Greater One-horned rhinoceros. However, further investigation of both vaccines is warranted to evaluate whether changes in the frequency of administration, dosage, or adjuvant might stimulate an improved humoral response in these animals.

Suggested guidelines for use of avian species as biomonitors.

An animal's suitability as a biomonitor of environmental change can be determined by biological, reproductive and ecological characteristics determined at the class, order and species level. The animal's habitat where the research is to be performed and the form, function and structure of the environmental change being studied within that habitat also determines suitability. Non-threatened populations of large, non-migratory, long-lived, seasonally-breeding tertiary avian predators, whose dietary preferences are narrow and known, can be useful as monitors of environmental chemical contaminants. If chemicals are being monitored, a quantifiable endpoint effect must be demonstrated in the species, or a similar species under experimental laboratory conditions. Logistical and economic issues as well as public and regulatory authority acceptance should also be considered when assessing the suitability of a species as a biomonitor.

Single-dose intravenous and oral pharmacokinetics of enrofloxacin in goral (Nemorrhaedus goral arnouxianus).

This study describes the pharmacokinetics of enrofloxacin following oral and i.v. administration to goral (Nemorrhaedus goral arnouxianus). The objective of this study was to expand upon current antimicrobial treatment options available for use in goral by measuring plasma concentrations and examining the pharmacokinetics of enrofloxacin in these animals. Two single-dose treatments of enrofloxacin were administered to four goral in a crossover design. Single-dose treatments consisted of administration of injectable enrofloxacin i.v. (5 mg/kg) and enrofloxacin tablets (136 mg chewable tablets) dissolved in a grain slurry and administered p.o. (10 mg/kg). Plasma levels of enrofloxacin and its metabolite ciprofloxacin were measured with the use of high-performance liquid chromatography with UV detection. Plasma volume of distribution for i.v. enrofloxacin was 2.15 - 1.01 L/kg, with a mean elimination half-life of 13.3 hr and total body clearance of 0.19+/-0.14 L/kg/hr. The maximum plasma concentration measured for oral enrofloxacin was 2.77 microg/ml, with a mean half-life of 5.2 hr and systemic availability of 14.6%. The area under the plasma concentration over time curve (AUC) for oral enrofloxacin was 21.06 microg/hr/ml. The area under the plasma concentration over time curve generated for oral enrofloxacin in goral yields an area under the plasma concentration over time curve to minimum inhibitory concentration ratio > 100 for many gram-positive and gram-negative bacterial pathogens common to small ruminants. Based on these results, oral enrofloxacin may be considered for further study as a treatment option for susceptible infections in goral.

Serial chemical restraint for treatment of decubitus ulcers in two neonatal white rhinoceroses (Ceratotherium simum).

Two neonatal white rhinoceroses (Ceratotherium simum) at two zoological institutions were medically managed for wounds characterized by extensive multifocal necrosis of the skin and subcutaneous tissue, associated with decubitus ulcers throughout the body. Wounds resulted from prolonged recumbency due to inability to stand in one case and causes unconfirmed in the other. Both calves were born in cement stalls during winter. Using either butorphanol (i.v. or i.m.) alone or in combination with detomidine (i.m.), serial chemical restraint was conducted over a 6-wk period to facilitate wound care. Anesthesia was well tolerated in both calves, and lesions responded well to medical treatment.

Pharmacokinetics after intravenous, subcutaneous, and oral administration of enrofloxacin to alpacas.

OBJECTIVE: To determine plasma concentrations of enrofloxacin and the active metabolite ciprofloxacin after p.o, s.c., and i.v. administration of enrofloxacin to alpacas. ANIMALS: 6 adult female alpacas. PROCEDURE: A crossover design was used for administration of 3 single-dose treatments of enrofloxacin to alpacas, which was followed by an observational 14-day multiple-dose regimen. Single-dose treatments consisted of i.v. and s.c. administration of injectable enrofloxacin (5 mg/kg) and p.o administration of enrofloxacin tablets (10 mg/kg) dissolved in grain to form a slurry. Plasma enrofloxacin concentrations were measured by use of high-performance liquid chromatography. The multiple-dose regimen consisted of feeding a mixture of crushed and moistened enrofloxacin tablets mixed with grain. Behavior, appetite, and fecal quality were monitored throughout the 14-day treatment regimen and for 71 additional days following treatment. RESULTS: Mean half-life following i.v., s.c., and p.o. administration was 11.2, 8.7, and 16.1 hours, respectively. For s.c. and p.o administration, mean total systemic availability was 90.18% and 29.31%, respectively; mean maximum plasma concentration was 3.79 and 1.81 microg/mL, respectively; and area under the curve (AUC) was 50.05 and 33.97 (microg x h)/mL, respectively. The s.c. or p.o administration of a single dose of enrofloxacin yielded a ratio for AUC to minimum inhibitory concentration > 100 for many grampositive and gram-negative bacterial pathogens common to camelids. Conclusions and Clinical Relevance-The administration of enrofloxacin (5 mg/kg, s.c., or 10 mg/kg, p.o) may be appropriate for antimicrobial treatment of alpacas.

Mercury and persistent organic pollutant concentrations in African fish eagles, marabou storks, and Nile tilapia in Uganda.

The purpose of this research was to evaluate persistent organic pollutant (POP) and mercury concentrations in tissues of African fish eagles (Haliaeetus vocifer) and Nile tilapia (Oreochromis niloticus) from Lake Victoria near Entebbe and Lake Mburo, Uganda. Marabou stork (Leptoptilos crumeniferus) nestlings from urban Kampala (40 km from Entebbe) also were sampled for POPs and mercury. Total mercury was measured in the breast feathers of eight nestling and 10 adult African fish eagles from Lake Mburo, 10 nestling and five adult African fish eagles from Lake Victoria near Entebbe, and 20 nestling marabou storks from Kampala from June 2002 through January 2003. Mercury concentrations in all samples were below levels associated with adverse effects in similar species. Mercury concentrations were significantly higher in eagle adults and nestlings from Entebbe than in adults and nestlings from Lake Mburo (P< or =0.05). No significant differences (P> or =0.05) were found in mercury concentrations between sexes or between the entire fish eagle population sampled at Entebbe and marabou stork nestlings sampled at nearby Kampala. Plasma samples from the same birds were analyzed for 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane, aldrin, hexachlorocyclohexane (alpha-HCH), dieldrin, endrin, heptachlor and their metabolites, as well as total polychlorinated biphenyls (PCBs). Nile tilapia whole-body cross sections collected from Lake Mburo (n=3) and Lake Victoria near Entebbe (n=8) also were analyzed for these POPs and mercury. No samples contained POPs or PCBs at the limits of detection except for 4,4'-1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene in five adult eagle plasma samples (0.0026+/-0.0015 ppm wet weight) and five Nile tilapia samples (0.002+/-0.001 ppm wet weight) from Entebbe.

Clinical pathology and morphometrics of African fish eagles in Uganda.

Packed cell volumes (PCVs) and plasma chemistry parameters were measured in 15 adult and 18 nestling African fish eagles (Haliaeetus vocifer) sampled from June 2002 through January 2003 in Uganda. Morphologic measurements were obtained from 15 adult eagles. All eagles were examined for blood parasites and sexed by examination of DNA from red blood cells. Ten adults and eight nestlings were sampled from Lake Mburo and five adults and 10 nestlings were sampled from Lake Victoria near Entebbe, Uganda. Analysis of variance was conducted to assess the association between site, age, sex, and plasma chemistry parameters and the association between sex and morphologic characteristics. Plasma chemistry values for nestling and adult African fish eagles were similar to those reported for other captive and free-ranging eagle species. Packed cell volumes for nestling African fish eagles were markedly lower than values reported for nestlings of other eagle species, although the mean estimated age of nestlings sampled also was lower. A significant association (P < or =0.05) was found between PCV of nestling eagles and study site (lower at Lake Mburo) but no association was found between PCV and nestling body weight (P> or =0.05). An unidentified Plasmodium sp. was present in erythrocytes of three nestlings from Lake Mburo. No other blood parasites were seen. There was significant variation (P< or =0.05) in PCV, calcium, phosphorous, potassium, cholesterol concentrations, and creatine kinase activity between adults and nestlings; all were lower in adults. Aspartate transaminase activity was higher in adults. Like other Haliaeetus sp., body weight, bill depth, culmen length, footpad length, and hallux length as well as bill depth measurements were significantly (P < or = 0.05) greater for females than males. The objective of the study was to provide baseline biologic and physiologic information that may prove useful in the management and study of captive and wild populations of African fish eagles.

Clinical pathology of nestling marabou storks in Uganda.

Packed cell volumes (PCV) and plasma chemistry parameters were measured in 20 nestling marabou storks (Leptoptilos crumeniferus) in January 2003 that were a part of a colony located in the center of the city of Kampala, Uganda. There were no significant differences (P> or =0.05) in plasma chemistry values or PCV between sexes with the exception of globulin and total plasma protein values, which were higher in females. There were significant differences (P< or =0.05) in blood glucose, creatine kinase, and globulin levels between birds of different body weight. Total plasma protein, uric acid, phosphorous, and creatine kinase were generally higher relative to published data on other avian species, including nestling white storks (Ciconia ciconia).

Intraocular nematodiasis caused by Parelaphostrongylus tenuis in an eland antelope (Taurotragus oryx).

A 10-mo-old female eland (Taurotragus oryx) at the Wilds exhibited recalcitrant, progressive unilateral uveitis for a 5-wk period, despite constant medical treatment. Unilateral enucleation was performed because of blindness and animal discomfort evidenced by continuous blepharospasm. Histopathologic examination of the eye demonstrated intraocular larvae morphologically consistent with Parelaphostrongylus tenuis, the first known case of intraocular P. tenuis migration. This animal subsequently was euthanatized because of severe, nonresponsive neurologic signs associated with P. tenuis infection.

Repeated chemical immobilization of a captive greater one-horned rhinoceros (Rhinoceros unicornis), using combinations of etorphine, detomidine, and ketamine.

An adult, 23 yr-old, male greater one-horned rhinoceros (Rhinoceros unicornis) was repeatedly immobilized with combinations of etorphine, detomidine, and ketamine to provide medical and surgical care to chronic, bilateral, soft tissue lesions on the hind feet and to collect semen by electroejaculation. The rhinoceros was successfully immobilized on 24 occasions over a 55 mo period at approximately 8-10 wk intervals, 17 times with a combination of etorphine and detomidine (M99-D, i.m.) by projectile dart and seven times with a combination of etorphine, ketamine, and detomidine (M99-K-D, i.m.) by pole syringe. The combination of etorphine, detomidine, and ketamine repeatedly and safely induced prolonged anesthesia, and a suitable drug combination includes 3.5-3.8 mg etorphine, 14 mg detomidine, and 400 mg ketamine (M99-K-D) administered i.m. into the neck.